Document Detail

Long-term effects of dalfampridine in patients with multiple sclerosis.
MedLine Citation:
PMID:  24290498     Owner:  NLM     Status:  Publisher    
BACKGROUND/OBJECTIVE: Dalfampridine is the extended-release formulation of 4-aminopyridine and is approved for the symptomatic treatment of impaired mobility in patients with multiple sclerosis. Our aim was to examine the short- and long-term effects of treatment with dalfampridine on motoric and cognitive assessment parameters of multiple sclerosis (MS) patients over 9-12months.
METHODS: Fifty-two patients with MS with an EDSS between 4.0 and 7.0 and impaired mobility were evaluated for parameters of walking ability, MSFC, cognitive and motor fatigue and evoked potentials at treatment initiation with dalfampridine as well as 2weeks and after 9-12months later.
RESULTS: Thirty out of fifty-two patients (~60%) were still on treatment after 9-12months. Two weeks after treatment initiation, significant ameliorations could be found for T25FW, maximum walking distance as well as motoric and cognitive fatigue which still persisted after 9-12months. In contrast significant effects for velocity were observed only after 2weeks, for improvement in PASAT only after 9-12months. A tendency for improvement of somatosensory evoked potentials was found in a subset of patients.
CONCLUSION: Dalfampridine shows positive short- and long-term effects on motoric and cognitive assessment parameters in an open-label observational study in a cohort of patients with MS.
T Ruck; S Bittner; O J Simon; K Göbel; H Wiendl; M Schilling; S G Meuth
Related Documents :
9651718 - Fast pathway ablation in patients with common atrioventricular nodal reentrant tachycar...
7295428 - Complete heart block in mumps myocarditis.
9672408 - Esophageal pp intervals for analysis of short-term heart rate variability in patients w...
1743548 - Effects of posture, effort and psychophysiological activation on atrio-ventricular node...
15271018 - Radiofrequency catheter ablation for arrhythmic storm in patients with an implantable c...
19852148 - Valvular calcification and its relationship to atherosclerosis in chronic kidney disease.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-11-16
Journal Detail:
Title:  Journal of the neurological sciences     Volume:  -     ISSN:  1878-5883     ISO Abbreviation:  J. Neurol. Sci.     Publication Date:  2013 Nov 
Date Detail:
Created Date:  2013-12-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375403     Medline TA:  J Neurol Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Elsevier B.V. All rights reserved.
Department of Neurology - University of Münster, Albert-Schweitzer-Campus 1, Building A 10, 48149 Münster, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Temporal and regional patterns of Smad activation in the rat hippocampus following global ischemia.
Next Document:  Cauda equina involvement in Susac's syndrome.